EUVIMEDEUVIMED entdecken
Historischer BeitragOpen Access · CC BY 4.0

Learning with Patient Campaigners About a German Drug Scandal**

Jesse Olszynko-Gryn, Anja Suter, Edmund Bolger, Birgit Nemec iD

Berichte zur Wissenschaftsgeschichte · 2026-03 · 49 (1) · 50-65

DOI: 10.1002/bewi.70014 ↗

Kurz gefasst

Historischer Beitrag in der Zeitschrift Berichte zur Wissenschaftsgeschichte, online erschienen am 27.02.2026. Verfasst von Jesse Olszynko-Gryn und 3 weiteren Autor:innen. Beteiligte Einrichtung: Max-Planck-Institut für Wissenschaftsgeschichte, Boltzmannstraße 22, 14195, Berlin, Germany. Hauptthemen laut MEDLINE: Abnormalities, Drug-Induced, Abortion, Induced. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Arts and Humanities Research Council, European Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The West German drug Duogynon was internationally marketed as a “hormone pregnancy test” (HPT) between the 1950s and 1980s. In the late 1960s it came under suspicion for inducing miscarriage, spina bifida, and a spectrum of birth defects similar to those caused by the sedative thalidomide. In contrast to thalidomide, medical consensus did not form around the teratogenicity of Duogynon and many people who identify as Duogynon‐affected continue to campaign for recognition. The informal use of Duogynon as an abortion pill adds a further layer of shame, secrecy, and silence. In this article, we reflect on the value of oral history and the ethics of inclusion within a larger research project that investigates the rise and fall of HPTs, globally. We ask what collaborating with patient campaigners in a more participatory mode than is typical of archival research can contribute to the historical understanding of the Duogynon affair and other drug scandals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Abnormalities, Drug-InducedAbortion, InducedHumansGermanyHistory, 20th CenturyFemalePregnancySpinal Dysraphism

Stichwörter der Autor:innen

Duogynondisabilityethicshealth activisminclusionoral history

Autor:innen und Institutionen

  • Max-Planck-Institut für Wissenschaftsgeschichte, Boltzmannstraße 22, 14195, Berlin, Germany.
  • Institut für Geschichte der Medizin und Ethik in der Medizin, Charité - Universitätsmedizin Berlin, Thielallee 71, 14195, Berlin, Germany.
  • Independent Filmmaker,, Berlin, Germany.
  • Fakultätszentrum für transdisziplinäre historisch-kulturwissenschaftliche Studien, Universität Wien, Kolingasse 14-16, 1090, Wien, Austria.

ORCID-Profile: Birgit Nemec

Förderung

  • Deutsche Forschungsgemeinschaft
  • Arts and Humanities Research Council
  • European Research Council

Zitieren

APA

Olszynko-Gryn, J., Suter, A., Bolger, E., & Nemec, B. (2026). Learning with Patient Campaigners About a German Drug Scandal**. Berichte zur Wissenschaftsgeschichte, 49(1), 50-65. https://doi.org/10.1002/bewi.70014

Vancouver

Olszynko-Gryn J, Suter A, Bolger E, Nemec B. Learning with Patient Campaigners About a German Drug Scandal**. Berichte zur Wissenschaftsgeschichte. 2026;49(1):50-65. doi:10.1002/bewi.70014

BibTeX
@article{OlszynkoGryn2026,
  author = {Olszynko-Gryn, Jesse and Suter, Anja and Bolger, Edmund and Nemec, Birgit},
  title = {Learning with Patient Campaigners About a German Drug Scandal**},
  journal = {Berichte zur Wissenschaftsgeschichte},
  year = {2026},
  volume = {49},
  number = {1},
  pages = {50--65},
  doi = {10.1002/bewi.70014}
}
Kostenlos starten →